Abstract:Molecular interactions between paclitaxel, an anticancer drug, and phospholipids of various chain unsaturations and headgroup types were investigated in the present study by Langmuir film balance and differential scanning calorimetry. Both the lipid monolayer at the air-water interface and the lipid bilayer vesicles (liposomes) were employed as model cell membranes. It was found that, regardless of the difference in molecular structure of the lipid chains and headgroup, the drug can form nonideal, miscible systems with the lipids at the air-water interface over a wide range of paclitaxel mole fractions. The interaction between paclitaxel and phospholipid within the monolayer was dependent on the molecular area of the lipids at the interface and can be explained by intermolecular forces or geometric accommodation. Paclitaxel is more likely to form thermodynamically stable systems with 1,2-dipalmitoyl-sn-glycerol-3-phosphocholine (DPPC) and 1,2-dielaidoyi-sn-glycero-3-phosphocholine (DEPC) than with 1, 2-dipalinitoyl-sn-glycero-3-phosphoethanolamine (DPPE) and 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC). Investigation of the drug penetration into the lipid monolayer showed that DPPC and DEPC have higher incorporation abilities for the drug than DPPE and DSPC. A similar trend was also evidenced by DSC investigation with liposomes. While little change of DSC profiles was observed for the DPPE/paclitaxel and DSPC/paclitaxel liposomes, paclitaxel caused noticeable changes in the thermographs of DPPC and DEPC liposomes. Paclitaxel was found to cause broadening of the main phase transition without significant change in the peak melting temperature of the DPPC bilayers, which demonstrates that paclitaxel was localized in the outer hydrophobic cooperative zone of the bilayer, i.e., in the region of the C1-C8 carbon atoms of the acyl chain or binding at the polar head-roup site of the lipids. However, it may penetrate into the deeper hydrophobic zone of the DEPC bilayers. These findings provide useful information for liposomal formulation of anticancer drugs as well as for understanding drug-cell membrane interactions. (c) 2004 Elsevier Inc. All rights reserved.

Study on the inclusion of calix[8]arene carboxylic sodium with paclitaxel

Solubilization of Hydropropyl-Β-cyclodextrin to Paclitaxel and Its Relative Molecular Inclusion Mechanism

Photo-crosslinked Poly(ethylene Glycol)-B-poly(ϵ-caprolactone) Nanoparticles for Controllable Paclitaxel Release

Poly(ether-ester Anhydride)-Based Amphiphilic Block Copolymer Nanoparticle As Delivery Devices for Paclitaxel

Preparation of thermosensitive liposomes containing paclitaxel and their anticancer effect

Inclusion complexation and solubilization of paclitaxel by bridged bis(beta-cyclodextrin)s containing a tetraethylenepentaamino spacer.

Inclusion complexes of paclitaxel and oligo(ethylenediamino) bridged bis(β-cyclodextrin)s: solubilization and antitumor activity

Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel

Extraction Protocol and Liquid Chromatography/tandem Mass Spectrometry Method for Determining Micelle-Entrapped Paclitaxel at the Cellular and Subcellular Levels: Application to a Cellular Uptake and Distribution Study.

Preparation and in Vitro Evaluation of Paclitaxel-Loaded Poly(lactide-co-glycolide) Nanoparticles

Preparation,physicochemical characterization and cyctotoxicity of solid dispersion of paclitaxel and polyvinylpyrrolidone

Molecular interactions between lipid and paclitaxel (Taxol(R) ) within cell membrane simulated by the lipid monolayer at the air-water interface

Poly-tannic acid coated paclitaxel nanocrystals for combinational photothermal-chemotherapy

Eftects Of Lipid Chain Unsaturation And Headgroup Type On Molecular Interactions Between Paclitaxel And Phospholipid Within Model Biomembrane

Molecular dynamics of paclitaxel encapsulated by salicylic acid-grafted chitosan oligosaccharide aggregates.

Physicochemical properties and biocompatibility of a polymer-paclitaxel conjugate for cancer treatment.

Functionalized Pluronic-b-poly(ε-caprolactone) based nanocarriers of paclitaxel: solubilization, antiproliferative efficacy and in vivo pharmaceutic kinetics.

Preparation and Characterization of Paclitaxel Delivery System Based on Semi-Solid Lipid Nanoparticles Coated with Poly (ethylene Glycol).

Application of curcumin as a co-former and an efflux inhibitor in paclitaxel co-amorphous mixture

A novel preparative method for nanoparticle albumin-bound paclitaxel with high drug loading and its evaluation both in vitro and in vivo

Development and Evaluation of Transferrin-Stabilized Paclitaxel Nanocrystal Formulation.